
CAAT psychometric validation manuscript published
Now published in Respiratory Research: Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.
Read MoreThe NOVEL observational longiTudinal studY (NOVELTY) is a global, prospective, 3-year observational study of patients with a diagnosis or suspected diagnosis of asthma and/or COPD, with an additional 2-year extension study at participating sites. NOVELTY aims to describe patient characteristics, treatment patterns and disease burden over time across the spectrum of obstructive lung disease, providing real-world evidence to advance the development of precision medicine to deliver the right treatment to the right patient at the right time. The NOVELTY study is sponsored by AstraZeneca.
Now published in Respiratory Research: Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.
Read MoreNow published in ERJ Open Research: Functional imaging in asthma and COPD: design of the NOVELTY ADPro substudy.
Read MoreNow published in JACI: In Practice: Cluster analyses from the real‑world NOVELTY study: six clusters across the asthma‑COPD spectrum.
Read MoreRead summaries of publications and presentations relating to the NOVELTY study and access useful NOVELTY resources.
Read MoreYou are now leaving: http://aznoveltyproject.com/
By following this link you will be leaving the NOVELTY study website.
Please note that AstraZeneca does not take responsibility for the content displayed on other websites.